Ventas, Inc.
VTRReal Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.
- Revenue
- +23.0%
- EPS
- −7.14%
- Free cash flow
- +20.5%
- Total debt
- −1.07%
Quarter to September 2026, against a year earlier
After hours trading: 86.55, down 0.02%, last trade 7:28pm Eastern.
Follow VTR
Alert me
Ventas, Inc. (VTR) EV/EBITDA
As of Nov 20, 2026, Ventas, Inc. (VTR) trades at a EV/EBITDA of 22.6×. Over the past ten years it has ranged from 9.5× (March 2020) to 25.7× (July 2026); the current reading is higher than 90% of that period. That is above the Reit Healthcare Facilities industry median of 14.7× and above the Real Estate sector median of 14.7×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 21.3× | 10.39% |
| FY2024 | 19.3× | 1.48% |
| FY2023 | 19.0× | 3.64% |
| FY2022 | 18.3× | (10.19%) |
| FY2021 | 20.4× | 16.96% |
| FY2020 | 17.4× | 0.99% |
| FY2019 | 17.3× | 4.11% |
| FY2018 | 16.6× | 0.00% |
| FY2017 | 16.6× | (3.83%) |
| FY2016 | 17.3× | 5.06% |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 22.3× | (4.19%) |
| Jun 2026 | 23.3× | 4.76% |
| Mar 2026 | 22.2× | 4.37% |
| Dec 2025 | 21.3× | 2.89% |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| HR Healthcare Realty Trust Incorporated compare | 9.9× |
| NHI National Health Investors, Inc. compare | 13.3× |
| DOC Healthpeak Properties, Inc. compare | 14.7× |
| OHI Omega Healthcare Investors, Inc. compare | 16.8× |
| CTRE CareTrust REIT, Inc. compare | 19.5× |
| SBRA Sabra Healthcare REIT, Inc. compare | 19.5× |
| VTR Ventas, Inc. | 22.6× |
| AHR American Healthcare REIT, Inc. compare | 27.9× |
| WELL Welltower Inc. compare | 57.4× |
| Reit Healthcare Facilities industry median | 14.7× |
| Real Estate sector median | 14.7× |
| Market median | 9.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on VTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement